Current status of non-viral siRNA vectors for therapy of cancers

Huan WANG,Zhiqiang MA,Feng YANG
DOI: https://doi.org/10.3969/j.issn.1006-0111.2015.06.005
2015-01-01
Abstract:In the recent years ,siRNA has been widely used as effector molecule in the field of gene therapy for cancer . In order to achieve ideal treatment effect ,the key factor is to find safe ,efficient ,stable and controllable gene vectors .The commonly used vectors include viral and non-viral vectors .The non-viral gene vector has superiority of low toxicity ,bare im-munogenicity ,simple to manufacture and high capacity which have been taken as the highlight of the research of carrier of gene drugs .Based on the study of the previous researchers ,this study reviewed the prevalence study of the former carriers in the de-livery system of siRNA from the point of pharmaceutics .
What problem does this paper attempt to address?